Skip to search formSkip to main contentSkip to account menu

CBR 2092

Known as: CBR-2092, CBR2092 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

QuinolonesRifamycins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
4-Quinolone hybrids and their antibacterial activities.
2013
2013
Looking for the new preparations for antibacterial therapy III. New antimicrobial agents from the quinolones group in clinical trials.
There is an essential need for searching for the new compounds effective in the treatment of infections caused by multidrug… 
2009
2009
Fishing the target of antitubercular compounds: in silico target deconvolution model development and validation.
An in silico target prediction protocol for antitubercular (antiTB) compounds has been proposed in this work. This protocol is… 
2008
2008
In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci
ABSTRACT We present data from antimicrobial assays performed in vitro that pertain to the potential clinical utility of a novel… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)